Introduction {#s1}
============

Cerebrotendinous xanthomatosis (CTX) is a rare autosomal recessive neurometabolic disorder characterized by infantile or early childhood onset of chronic diarrhea, tendon xanthomas, cataracts, and neurological problems, such as behavioral disorders, cognitive impairment, peripheral neuropathy, dystonia, parkinsonism, epilepsy, myoclonus, and progressive cerebellar ataxia, that usually start in the second or third decades of life.[@b01],[@b02] This disease is caused by mutations in the *CYP27A1* gene that result in decreased production of chenodeoxycholic acid and elevated levels of cholestanol and bile alcohols.[@b03] Chenodeoxycholic acid is an established treatment that restores metabolic abnormalities and may improve or even prevent neurological deterioration,[@b04] especially if it is instituted at the early stages of the disease process.[@b05]

Case report {#s2}
===========

A 31-year-old female with no family history of neurological disease or consanguinity was evaluated after a 4-year history of gait instability, dysarthria, and dysphagia. She had a relevant history of chronic diarrhea at early childhood and depression since 20 years of age. Physical examination disclosed spasmodic-like dysphonia, altered saccadic eye movements, pyramidal signs, proximal and distal muscle wasting in the upper and lower limbs, palatal tremor at low frequency without ear or throat clicks, and mild limb and gait ataxia ([Video 1](#v01){ref-type="other"}). The Scale for the Assessment and Rating of Ataxia (SARA) score was 15. No tendon xanthomas were present ([Figure 1](#f01){ref-type="fig"}). Electromyography and a nerve conduction study revealed a sensorimotor axonal polyneuropathy. Brain magnetic resonance imaging (MRI) displayed mild cerebellar atrophy and bilateral hyperintensity of the dentate nuclei on fluid-attenuated inversion recovery and T2-weighted images, with a central hypointensity suggestive of calcification ([Figure 2A](#f02){ref-type="fig"}, left and central) and bilateral hyperintensity of the basal ganglia ([Figure 2A](#f02){ref-type="fig"}, right). The olivary nuclei showed a serpiginous abnormal signal, although there was no classic olivary hypertrophy ([Figure 2B](#f02){ref-type="fig"}, left). A brain computed tomography scan showed subtle calcifications in the white matter surrounding the dentate nucleus ([Figure 2B](#f02){ref-type="fig"}, right). Routine work-up studies for ataxia, such as alpha-fetoprotein, thyroid function and anti-thyroid peroxidase antibodies, celiac disease antibodies (transglutaminase, anti-gliadin, and anti-endomysial), anti-neuronal antibodies, ceruloplasmin, human immunodeficiency virus, cupruria, vitamin B1, B12, and vitamin E levels were normal or negative, except for plasmatic cholesterol levels, which were low (111 mg/dL). CAG repeat determination in the *ATXN1*, *ATXN2*, *ATXN3*, *CACNA1A*, and *ATXN7* genes were negative. Whole-exome sequencing detected two heterozygous variants (c.1183C\>T p.(Arg395Cys) and c.1184+1G\>A) in the *trans*-phase in the *CYP27A1* gene consistent with a diagnosis of CTX. Cholestanol levels in the serum and tendons were not available for evaluation in our patient. Treatment with chenodeoxycholic acid was started, with improvement of irritability and gait instability (SARA scores slightly improved from 15 to 14 points because of a change in the item that measures stance) and weight gain.

###### Cerebrotendinous xanthomatosis revealed by ataxia and palatal tremor in the absence of tendon xanthomas and cataracts. A 30-year-old female with genetically confirmed cerebrotendinous xanthomatosis showing mild limb and gait ataxia (Segment 1A and 1B) and palatal tremor at low frequency (Segment 1C).

![Imaging of both feet. Atrophy of the distal foot muscles and absence of xanthomas in the Achilles tendons. There were also no xanthomas in other body parts.](tre-08-538-7522-1-g001){#f01}

![Brain Magnetic Resonance Imaging. (A) Flair and T2-weighted images display mild cerebellar atrophy and bilateral hyperintensity of the dentate nuclei on Flair and T2-weighted images with a central hypointensity suggestive of calcification (left and central). Bilateral hyperintensity of the basal ganglia (right). (B) Olivary nuclei with a serpingous abnormal signal (left). Subtle calcifications in the white matter surrounding the dentate nucleus (right).](tre-08-538-7522-1-g002){#f02}

Discussion {#s3}
==========

This patient with CTX exhibited palatal tremor and progressive ataxia as the most prominent clinical signs, but without tendon xanthomas and juvenile cataracts, which are clinical hallmarks of CTX. The frequency of juvenile cataracts and tendon xanthomas in CTX patients averages 88% and 78%, respectively.[@b06] We cannot rule out the possibility that both problems can appear later in the course of the disease. However, this possibility would be very low, as approximately 75% of CTX patients present with cataracts, often appearing in the first decade of life, whereas xanthomas commonly develop in the second or third decade.[@b06],[@b07] Large deposits of cholesterol and cholestanol, the 5-alpha-dihydro derivative of cholesterol, are found in virtually every tissue, particularly the Achilles tendons.[@b07] Low cholesterol and high cholestanol levels in the serum and tendons support the diagnosis of this entity, besides genetic testing.[@b03],[@b07] Reports of palatal tremor (also referred previously as palatal myoclonus) in genetically confirmed patients with CTX are rare.[@b08],[@b09] This atypical case combines palatal tremor and ataxia in the absence of the most characteristic clinical features of CTX, thus highlighting the phenotypic variability of this genetic entity. The syndrome of familial or sporadic progressive ataxia and palatal tremor (PAPT) is rare in clinical practice and the cause usually remains uncertain.[@b10],[@b11] In the sporadic form, brain MRI frequently shows hyperintensity in the inferior olivary nuclei.[@b10] Even though no classic olivary hypertrophy was found in the patient described here, the olivary nuclei contained a serpiginous abnormal signal suggestive of a "forme fruste" or variant of olivary hypertrophic degeneration. Also, olivary hypertrophy may not be evident with routine MRI sequences, and its presence depends on the stage of olivary degeneration.[@b12] Despite the subtle olivary nuclei abnormalities, the clinical picture may exceed the classical PAPT syndrome.

A number of differential diagnoses must be considered in patients with progressive ataxia and palatal tremor. For example, the combination of ataxia, palatal tremor, dysphonia resembling spasmodic dysphonia, and dentate calcifications may orient to spinocerebellar ataxia type 20.[@b13] The hyperintensities observed in the dentate nucleus and the surrounding white matter are common features reported in CTX.[@b14] Other entities that present with progressive ataxia and palatal tremor are listed in [Table 1](#t01){ref-type="table"}. A functional disruption in the "Mollaret's triangle", formed by the red, dentate, and inferior olivary nuclei has been postulated as the cause of palatal tremor.[@b15] Presumably, in this patient, the palatal tremor arose because of a disruption of the dentatorubroolivary circuit secondary to the lesions in the olivary nuclei and dentate nuclei.

Table 1Differential Diagnosis of Progressive Ataxia and Palatal TremorDisease Name (Gene)InheritanceMain Clinical Features Besides Ataxia and Palatal TremorMRI FindingsSpinocerebellar ataxia type 20 (SCA20)[@b13],[@b17]ADDysphonia resembling spasmodic dysphonia, dysarthria, hypermetric saccades, postural tremor, pyramidal signsDentate calcifications and cerebellar atrophySpastic paraplegia type 7 or HSP/ATX-SPG7 (SPG7)[@b18]AR/ADSpastic paraparesis, optic atrophy, nystagmus, chronic external ophthalmoplegia-like phenotype, pes cavus, decreased vibratory sense in the lower limbs, scoliosisCerebellar and spinal cord atrophyNeuroferritinopathy or NBIA/CHOR-FTL (FTL)[@b19],[@b20]ADChorea, oromandibular dyskinesia, dystonia, parkinsonism, dysphagia, psychiatric symptoms, cognitive impairmentIron accumulation in globus pallidus, caudate, putamen, substantia nigra, red nucleus; cystic basal ganglia changes and pallidal necrosisAlexander disease (GFAP)[@b10],[@b21]--[@b23]ADPsychomotor regression, spasticity, seizures, pyramidal signs, pseudobulbar signs, macrocephalyExtensive cerebral white-matter abnormalities with a frontal preponderance, periventricular rim, basal ganglia abnormalities, hydrocephalusPOLG-related disorders (POLG)[@b24]--[@b27]ARDystonia, chorea, myoclonus, tremor, progressive external ophthalmoplegia, seizures, cognitive impairment, psychiatric symptoms, cataracts, optic atrophy, peripheral neuropathy, muscle weakness and atrophy, hypogonadism, stroke-like episodesCerebellar atrophy or normalGM2-gangliosidosis type II or Sandhoff disease (HEXB)[@b28]ARProgressive mental and motor deterioration, macular cherry red spot, blindness, spastic paraparesis, muscular atrophy, fasciculations, dysmorphic features, startle reaction, cardiomegaly, episodic abdominal pain, chronic diarrhea, hepatosplenomegalyBilateral symmetric thalamic lesions, hyperintensities in the periventricular, deep, and subcortical white matter, delayed myelinationProgressive ataxia and palatal tremor due to a four-repeat tauopathy[@b29],[@b30]SporadicDysarthria, dysphagia, hearing loss, blurring vision, nystagmusT2 hyperintensities in the bilateral inferior olivary nuclei and cerebellar atrophyProgressive ataxia and palatal tremor syndrome[@b10],[@b31],[@b32]Sporadic (rarely familial)Dysarthria, nystagmusT2 hyperintensity and hypertrophy of the bilateral inferior olivary nuclei and cerebellar atrophyGluten sensitivity ataxia[@b33]SporadicDysarthriaT2 hyperintensity and hypertrophy of the bilateral inferior olivary nuclei and cerebellar atrophyMultiple system atrophy (cerebellar subtype)[@b19]SporadicAutonomic failure, action tremor, nystagmus, pyramidal signs, dysarthria, dysphagiaAtrophy of the putamen, middle cerebellar peduncle, or pons. The "hot-cross-bun sign" (cruciform hyperintensity in the pons) in T2-weighted sequences[^1]

Neurologists should consider CTX when ataxia, palatal tremor, and dentate nuclei hyperintensities are present, even in the absence of tendon xanthomas and cataracts. Patients with progressive ataxia and palatal tremor should be exhaustively studied, because some cases, as the one described here, are not sporadic, but of genetic origin and also susceptible to specific treatment.[@b16] CTX should be added to the differential diagnosis of progressive ataxia and palatal tremor.
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[^1]: Abbreviations: AD, Autosomal Dominant; AR, Autosomal Recessive; MRI, Magnetic Resonance Imaging.
